View in EDS HTML Full Text PDF Full Text

Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial.
Authors: Shcherbinin S; Eli Lilly and Company, Indianapolis, Indiana., Evans CD; Eli Lilly and Company, Indianapolis, Indiana., Lu M; Eli Lilly and Company, Indianapolis, Indiana.; Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, Philadelphia, Pennsylvania., Andersen SW; Eli Lilly and Company, Indianapolis, Indiana., Pontecorvo MJ; Eli Lilly and Company, Indianapolis, Indiana.; Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, Philadelphia, Pennsylvania., Willis BA; Eli Lilly and Company, Indianapolis, Indiana.; Now with Eisai Inc, Nutley, New Jersey., Gueorguieva I; Eli Lilly and Company, Indianapolis, Indiana., Hauck PM; Eli Lilly and Company, Indianapolis, Indiana., Brooks DA; Eli Lilly and Company, Indianapolis, Indiana., Mintun MA; Eli Lilly and Company, Indianapolis, Indiana.; Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, Philadelphia, Pennsylvania., Sims JR; Eli Lilly and Company, Indianapolis, Indiana.
Source: JAMA neurology [JAMA Neurol] 2022 Oct 01; Vol. 79 (10), pp. 1015-1024.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36094645
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shcherbinin+S%22">Shcherbinin S</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.<br /><searchLink fieldCode="AU" term="%22Evans+CD%22">Evans CD</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.<br /><searchLink fieldCode="AU" term="%22Lu+M%22">Lu M</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.; Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Andersen+SW%22">Andersen SW</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.<br /><searchLink fieldCode="AU" term="%22Pontecorvo+MJ%22">Pontecorvo MJ</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.; Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Willis+BA%22">Willis BA</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.; Now with Eisai Inc, Nutley, New Jersey.<br /><searchLink fieldCode="AU" term="%22Gueorguieva+I%22">Gueorguieva I</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.<br /><searchLink fieldCode="AU" term="%22Hauck+PM%22">Hauck PM</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.<br /><searchLink fieldCode="AU" term="%22Brooks+DA%22">Brooks DA</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.<br /><searchLink fieldCode="AU" term="%22Mintun+MA%22">Mintun MA</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.; Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Sims+JR%22">Sims JR</searchLink>; Eli Lilly and Company, Indianapolis, Indiana.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101589536%22">JAMA neurology</searchLink> [JAMA Neurol] 2022 Oct 01; Vol. 79 (10), pp. 1015-1024.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589536 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6157 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686149%22">21686149 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Neurol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36094645
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamaneurol.2022.2793
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1015
    Titles:
      – TitleFull: Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shcherbinin S
      – PersonEntity:
          Name:
            NameFull: Evans CD
      – PersonEntity:
          Name:
            NameFull: Lu M
      – PersonEntity:
          Name:
            NameFull: Andersen SW
      – PersonEntity:
          Name:
            NameFull: Pontecorvo MJ
      – PersonEntity:
          Name:
            NameFull: Willis BA
      – PersonEntity:
          Name:
            NameFull: Gueorguieva I
      – PersonEntity:
          Name:
            NameFull: Hauck PM
      – PersonEntity:
          Name:
            NameFull: Brooks DA
      – PersonEntity:
          Name:
            NameFull: Mintun MA
      – PersonEntity:
          Name:
            NameFull: Sims JR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2022 Oct 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2168-6157
          Numbering:
            – Type: volume
              Value: 79
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: JAMA neurology
              Type: main
ResultId 1